Posterior reversible encephalopathy syndrome (PRES) and hypomagnesemia: A frequent association?

被引:35
作者
Chardain, A. [1 ]
Mesnage, V. [1 ]
Alamowitch, S. [1 ]
Bourdain, F. [2 ]
Crozier, S. [3 ]
Lenglet, T. [4 ]
Psimaras, D. [4 ]
Demeret, S. [5 ]
Graveleau, P. [2 ]
Hoang-Xuan, K. [4 ]
Levy, R. [1 ]
机构
[1] Hop St Antoine, AP HP, Dept Neurol, 184 Rue Faubourg St Antoine, F-75012 Paris, France
[2] Ctr Med Chirurg Foch, Dept Neurol, F-92150 Suresnes, France
[3] Hop La Pitie Salpetriere, AP HP, Dept Cerebrovasc Emergency, F-75013 Paris, France
[4] Hop La Pitie Salpetriere, AP HP, Dept Neurol, F-75013 Paris, France
[5] Hop La Pitie Salpetriere, AP HP, Dept Neurol, Intens Care Unit, F-75013 Paris, France
关键词
Posterior reversible encephalopathy syndrome (PRES); Magnesium; Hypomagnesemia; Eclampsia; Hypertensive encephalopathy; MAGNESIUM-SULFATE; ECLAMPSIA;
D O I
10.1016/j.neurol.2016.06.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Posterior reversible encephalopathy syndrome (PRES) is a serious neurological condition encountered in various medical fields. Pathophysiological factor(s) common to PRES cases of apparently unrelated etiologies are yet to be found. Based on the hypothesis that hypomagnesemia might participate in the cascade leading to PRES, our study sought to verify whether hypomagnesemia is frequently associated with PRES regardless of etiology. From a retrospective study of a cohort of 57 patients presenting with PRES of different etiologies, presented here are the findings of 19 patients with available serum magnesium levels (SMLs) during PRES. In the acute phase of PRES, hypomagnesemia was present in all 19 patients in spite of differences in etiology (including immunosuppressive drugs, hypertensive encephalopathy, eclampsia, systemic lupus erythematosus, iatrogenic etiology and unknown). SMLs were within normal ranges prior to PRES and below normal ranges during the first 48 h of PRES, with a significant decrease in SMLs during the acute phase. In this retrospective study, constant hypomagnesemia was observed during the acute phase of PRES regardless of its etiology. These results now require larger studies to assess the particular importance of acute hypomagnesemia in PRES and especially the possible need to treat PRES with magnesium sulfate. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:384 / 388
页数:5
相关论文
共 10 条
[1]   Posterior reversible encephalopathy syndrome, part 1: Fundamental imaging and clinical features [J].
Bartynski, W. S. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2008, 29 (06) :1036-1042
[2]   Posterior reversible encephalopathy syndrome, part 2: Controversies surrounding pathophysiology of vasogenic edema [J].
Bartynski, W. S. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2008, 29 (06) :1043-1049
[3]   A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia [J].
Belfort, MA ;
Anthony, J ;
Saade, GR ;
Allen, JC .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (04) :304-311
[4]   Magnesium sulphate treatment decreases blood-brain barrier permeability during acute hypertension in pregnant rats [J].
Euser, Anna G. ;
Bullinger, Lisa ;
Cipolla, Marilyn J. .
EXPERIMENTAL PHYSIOLOGY, 2008, 93 (02) :254-261
[5]   Magnesium Sulfate for the Treatment of Eclampsia A Brief Review [J].
Euser, Anna G. ;
Cipolla, Marilyn J. .
STROKE, 2009, 40 (04) :1169-1175
[6]   A reversible posterior leukoencephalopathy syndrome [J].
Hinchey, J ;
Chaves, C ;
Appignani, B ;
Breen, J ;
Pao, L ;
Wang, A ;
Pessin, MS ;
Lamy, C ;
Mas, JL ;
Caplan, LR .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :494-500
[7]   HYPERTENSIVE ENCEPHALOPATHY - FINDINGS ON CT, MR IMAGING, AND SPECT IMAGING IN 14 CASES [J].
SCHWARTZ, RB ;
JONES, KM ;
KALINA, P ;
BAJAKIAN, RL ;
MANTELLO, MT ;
GARADA, B ;
HOLMAN, BL .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1992, 159 (02) :379-383
[8]   The Magpie Trial [J].
Sibai, BM .
LANCET, 2002, 360 (9342) :1329-1329
[9]   Role of magnesium in hypertension [J].
Sontia, Bruno ;
Touyz, Rhian M. .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2007, 458 (01) :33-39
[10]  
THOMPSON CB, 1984, LANCET, V2, P1116